nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—Alkylating Activity—Altretamine—ovarian cancer	0.258	0.465	CiPCiCtD
Ifosfamide—testicular cancer—ovarian cancer	0.155	0.511	CtDrD
Ifosfamide—germ cell cancer—ovarian cancer	0.149	0.489	CtDrD
Ifosfamide—Alkylating Activity—Chlorambucil—ovarian cancer	0.148	0.267	CiPCiCtD
Ifosfamide—Alkylating Activity—Melphalan—ovarian cancer	0.148	0.267	CiPCiCtD
Ifosfamide—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0089	0.123	CbGbCtD
Ifosfamide—CYP3A7—Paclitaxel—ovarian cancer	0.0089	0.123	CbGbCtD
Ifosfamide—CYP3A5—Paclitaxel—ovarian cancer	0.00668	0.0921	CbGbCtD
Ifosfamide—CYP3A7—Docetaxel—ovarian cancer	0.00644	0.0888	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.00644	0.0888	CbGbCtD
Ifosfamide—CYP2C8—Paclitaxel—ovarian cancer	0.00642	0.0886	CbGbCtD
Ifosfamide—CYP3A4—Topotecan—ovarian cancer	0.00526	0.0726	CbGbCtD
Ifosfamide—CYP3A5—Docetaxel—ovarian cancer	0.00483	0.0666	CbGbCtD
Ifosfamide—CYP2B6—Doxorubicin—ovarian cancer	0.00457	0.063	CbGbCtD
Ifosfamide—CYP2C9—Paclitaxel—ovarian cancer	0.00448	0.0618	CbGbCtD
Ifosfamide—CYP3A4—Vinorelbine—ovarian cancer	0.00371	0.0511	CbGbCtD
Ifosfamide—CYP3A4—Paclitaxel—ovarian cancer	0.0026	0.0359	CbGbCtD
Ifosfamide—CYP3A4—Docetaxel—ovarian cancer	0.00188	0.026	CbGbCtD
Ifosfamide—CYP3A4—Doxorubicin—ovarian cancer	0.0014	0.0194	CbGbCtD
Ifosfamide—Cyclophosphamide—ABCB1—ovarian cancer	0.000216	1	CrCbGaD
Ifosfamide—Angina pectoris—Epirubicin—ovarian cancer	2.1e-05	0.000308	CcSEcCtD
Ifosfamide—Thrombocytopenia—Paclitaxel—ovarian cancer	2.1e-05	0.000308	CcSEcCtD
Ifosfamide—Breast disorder—Doxorubicin—ovarian cancer	2.08e-05	0.000306	CcSEcCtD
Ifosfamide—Skin disorder—Paclitaxel—ovarian cancer	2.08e-05	0.000306	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	2.07e-05	0.000305	CcSEcCtD
Ifosfamide—Hyperhidrosis—Paclitaxel—ovarian cancer	2.07e-05	0.000304	CcSEcCtD
Ifosfamide—Anaemia—Docetaxel—ovarian cancer	2.05e-05	0.000302	CcSEcCtD
Ifosfamide—Pancytopenia—Epirubicin—ovarian cancer	2.04e-05	0.000301	CcSEcCtD
Ifosfamide—Anorexia—Paclitaxel—ovarian cancer	2.04e-05	0.0003	CcSEcCtD
Ifosfamide—Vomiting—Vinorelbine—ovarian cancer	2.02e-05	0.000298	CcSEcCtD
Ifosfamide—Dysuria—Epirubicin—ovarian cancer	2.01e-05	0.000296	CcSEcCtD
Ifosfamide—Rash—Vinorelbine—ovarian cancer	2.01e-05	0.000295	CcSEcCtD
Ifosfamide—Dermatitis—Vinorelbine—ovarian cancer	2e-05	0.000295	CcSEcCtD
Ifosfamide—Hypotension—Paclitaxel—ovarian cancer	2e-05	0.000294	CcSEcCtD
Ifosfamide—Leukopenia—Docetaxel—ovarian cancer	1.99e-05	0.000293	CcSEcCtD
Ifosfamide—Pollakiuria—Epirubicin—ovarian cancer	1.99e-05	0.000292	CcSEcCtD
Ifosfamide—Palpitations—Docetaxel—ovarian cancer	1.96e-05	0.000289	CcSEcCtD
Ifosfamide—Pancreatitis—Doxorubicin—ovarian cancer	1.95e-05	0.000287	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	1.95e-05	0.000287	CcSEcCtD
Ifosfamide—Hyperglycaemia—Epirubicin—ovarian cancer	1.94e-05	0.000285	CcSEcCtD
Ifosfamide—Cough—Docetaxel—ovarian cancer	1.94e-05	0.000285	CcSEcCtD
Ifosfamide—Angina pectoris—Doxorubicin—ovarian cancer	1.94e-05	0.000285	CcSEcCtD
Ifosfamide—Pneumonia—Epirubicin—ovarian cancer	1.93e-05	0.000284	CcSEcCtD
Ifosfamide—Convulsion—Docetaxel—ovarian cancer	1.93e-05	0.000283	CcSEcCtD
Ifosfamide—Paraesthesia—Paclitaxel—ovarian cancer	1.92e-05	0.000283	CcSEcCtD
Ifosfamide—Hypertension—Docetaxel—ovarian cancer	1.92e-05	0.000282	CcSEcCtD
Ifosfamide—Infestation NOS—Epirubicin—ovarian cancer	1.92e-05	0.000282	CcSEcCtD
Ifosfamide—Infestation—Epirubicin—ovarian cancer	1.92e-05	0.000282	CcSEcCtD
Ifosfamide—Dyspnoea—Paclitaxel—ovarian cancer	1.91e-05	0.000281	CcSEcCtD
Ifosfamide—Somnolence—Paclitaxel—ovarian cancer	1.9e-05	0.00028	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	1.9e-05	0.00028	CcSEcCtD
Ifosfamide—Myalgia—Docetaxel—ovarian cancer	1.89e-05	0.000278	CcSEcCtD
Ifosfamide—Chest pain—Docetaxel—ovarian cancer	1.89e-05	0.000278	CcSEcCtD
Ifosfamide—Arthralgia—Docetaxel—ovarian cancer	1.89e-05	0.000278	CcSEcCtD
Ifosfamide—Pancytopenia—Doxorubicin—ovarian cancer	1.89e-05	0.000278	CcSEcCtD
Ifosfamide—Nausea—Vinorelbine—ovarian cancer	1.89e-05	0.000278	CcSEcCtD
Ifosfamide—Renal failure—Epirubicin—ovarian cancer	1.89e-05	0.000277	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Epirubicin—ovarian cancer	1.88e-05	0.000277	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	1.88e-05	0.000276	CcSEcCtD
Ifosfamide—Stomatitis—Epirubicin—ovarian cancer	1.87e-05	0.000275	CcSEcCtD
Ifosfamide—Conjunctivitis—Epirubicin—ovarian cancer	1.86e-05	0.000274	CcSEcCtD
Ifosfamide—Dysuria—Doxorubicin—ovarian cancer	1.86e-05	0.000274	CcSEcCtD
Ifosfamide—Decreased appetite—Paclitaxel—ovarian cancer	1.86e-05	0.000274	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	1.85e-05	0.000272	CcSEcCtD
Ifosfamide—Fatigue—Paclitaxel—ovarian cancer	1.85e-05	0.000271	CcSEcCtD
Ifosfamide—Pollakiuria—Doxorubicin—ovarian cancer	1.84e-05	0.000271	CcSEcCtD
Ifosfamide—Pain—Paclitaxel—ovarian cancer	1.83e-05	0.000269	CcSEcCtD
Ifosfamide—Constipation—Paclitaxel—ovarian cancer	1.83e-05	0.000269	CcSEcCtD
Ifosfamide—Haematuria—Epirubicin—ovarian cancer	1.83e-05	0.000269	CcSEcCtD
Ifosfamide—Confusional state—Docetaxel—ovarian cancer	1.83e-05	0.000269	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Epirubicin—ovarian cancer	1.81e-05	0.000267	CcSEcCtD
Ifosfamide—Anaphylactic shock—Docetaxel—ovarian cancer	1.81e-05	0.000267	CcSEcCtD
Ifosfamide—Oedema—Docetaxel—ovarian cancer	1.81e-05	0.000267	CcSEcCtD
Ifosfamide—Infection—Docetaxel—ovarian cancer	1.8e-05	0.000265	CcSEcCtD
Ifosfamide—Hyperglycaemia—Doxorubicin—ovarian cancer	1.8e-05	0.000264	CcSEcCtD
Ifosfamide—Agranulocytosis—Epirubicin—ovarian cancer	1.79e-05	0.000263	CcSEcCtD
Ifosfamide—Pneumonia—Doxorubicin—ovarian cancer	1.79e-05	0.000263	CcSEcCtD
Ifosfamide—Nervous system disorder—Docetaxel—ovarian cancer	1.78e-05	0.000262	CcSEcCtD
Ifosfamide—Thrombocytopenia—Docetaxel—ovarian cancer	1.78e-05	0.000261	CcSEcCtD
Ifosfamide—Infestation NOS—Doxorubicin—ovarian cancer	1.78e-05	0.000261	CcSEcCtD
Ifosfamide—Infestation—Doxorubicin—ovarian cancer	1.78e-05	0.000261	CcSEcCtD
Ifosfamide—Feeling abnormal—Paclitaxel—ovarian cancer	1.76e-05	0.000259	CcSEcCtD
Ifosfamide—Skin disorder—Docetaxel—ovarian cancer	1.76e-05	0.000259	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	1.76e-05	0.000259	CcSEcCtD
Ifosfamide—Bradycardia—Epirubicin—ovarian cancer	1.75e-05	0.000258	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Paclitaxel—ovarian cancer	1.75e-05	0.000257	CcSEcCtD
Ifosfamide—Renal failure—Doxorubicin—ovarian cancer	1.74e-05	0.000257	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Doxorubicin—ovarian cancer	1.74e-05	0.000256	CcSEcCtD
Ifosfamide—Haemoglobin—Epirubicin—ovarian cancer	1.73e-05	0.000255	CcSEcCtD
Ifosfamide—Stomatitis—Doxorubicin—ovarian cancer	1.73e-05	0.000254	CcSEcCtD
Ifosfamide—Anorexia—Docetaxel—ovarian cancer	1.73e-05	0.000254	CcSEcCtD
Ifosfamide—Conjunctivitis—Doxorubicin—ovarian cancer	1.73e-05	0.000254	CcSEcCtD
Ifosfamide—Haemorrhage—Epirubicin—ovarian cancer	1.72e-05	0.000253	CcSEcCtD
Ifosfamide—Hepatitis—Epirubicin—ovarian cancer	1.72e-05	0.000253	CcSEcCtD
Ifosfamide—Urinary tract disorder—Epirubicin—ovarian cancer	1.7e-05	0.00025	CcSEcCtD
Ifosfamide—Urticaria—Paclitaxel—ovarian cancer	1.7e-05	0.00025	CcSEcCtD
Ifosfamide—Hypotension—Docetaxel—ovarian cancer	1.7e-05	0.000249	CcSEcCtD
Ifosfamide—Haematuria—Doxorubicin—ovarian cancer	1.69e-05	0.000249	CcSEcCtD
Ifosfamide—Connective tissue disorder—Epirubicin—ovarian cancer	1.69e-05	0.000249	CcSEcCtD
Ifosfamide—Abdominal pain—Paclitaxel—ovarian cancer	1.69e-05	0.000249	CcSEcCtD
Ifosfamide—Body temperature increased—Paclitaxel—ovarian cancer	1.69e-05	0.000249	CcSEcCtD
Ifosfamide—Urethral disorder—Epirubicin—ovarian cancer	1.69e-05	0.000248	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Doxorubicin—ovarian cancer	1.68e-05	0.000247	CcSEcCtD
Ifosfamide—Visual impairment—Epirubicin—ovarian cancer	1.66e-05	0.000244	CcSEcCtD
Ifosfamide—Agranulocytosis—Doxorubicin—ovarian cancer	1.66e-05	0.000244	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	1.65e-05	0.000243	CcSEcCtD
Ifosfamide—Paraesthesia—Docetaxel—ovarian cancer	1.63e-05	0.00024	CcSEcCtD
Ifosfamide—Erythema multiforme—Epirubicin—ovarian cancer	1.63e-05	0.00024	CcSEcCtD
Ifosfamide—Bradycardia—Doxorubicin—ovarian cancer	1.62e-05	0.000239	CcSEcCtD
Ifosfamide—Dyspnoea—Docetaxel—ovarian cancer	1.62e-05	0.000238	CcSEcCtD
Ifosfamide—Somnolence—Docetaxel—ovarian cancer	1.61e-05	0.000237	CcSEcCtD
Ifosfamide—Eye disorder—Epirubicin—ovarian cancer	1.61e-05	0.000237	CcSEcCtD
Ifosfamide—Tinnitus—Epirubicin—ovarian cancer	1.61e-05	0.000236	CcSEcCtD
Ifosfamide—Haemoglobin—Doxorubicin—ovarian cancer	1.6e-05	0.000236	CcSEcCtD
Ifosfamide—Flushing—Epirubicin—ovarian cancer	1.6e-05	0.000235	CcSEcCtD
Ifosfamide—Cardiac disorder—Epirubicin—ovarian cancer	1.6e-05	0.000235	CcSEcCtD
Ifosfamide—Hepatitis—Doxorubicin—ovarian cancer	1.59e-05	0.000234	CcSEcCtD
Ifosfamide—Haemorrhage—Doxorubicin—ovarian cancer	1.59e-05	0.000234	CcSEcCtD
Ifosfamide—Decreased appetite—Docetaxel—ovarian cancer	1.58e-05	0.000232	CcSEcCtD
Ifosfamide—Hypersensitivity—Paclitaxel—ovarian cancer	1.58e-05	0.000232	CcSEcCtD
Ifosfamide—Urinary tract disorder—Doxorubicin—ovarian cancer	1.57e-05	0.000231	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Docetaxel—ovarian cancer	1.57e-05	0.00023	CcSEcCtD
Ifosfamide—Connective tissue disorder—Doxorubicin—ovarian cancer	1.57e-05	0.00023	CcSEcCtD
Ifosfamide—Fatigue—Docetaxel—ovarian cancer	1.56e-05	0.00023	CcSEcCtD
Ifosfamide—Angiopathy—Epirubicin—ovarian cancer	1.56e-05	0.00023	CcSEcCtD
Ifosfamide—Urethral disorder—Doxorubicin—ovarian cancer	1.56e-05	0.00023	CcSEcCtD
Ifosfamide—Immune system disorder—Epirubicin—ovarian cancer	1.56e-05	0.000229	CcSEcCtD
Ifosfamide—Mediastinal disorder—Epirubicin—ovarian cancer	1.55e-05	0.000228	CcSEcCtD
Ifosfamide—Pain—Docetaxel—ovarian cancer	1.55e-05	0.000228	CcSEcCtD
Ifosfamide—Constipation—Docetaxel—ovarian cancer	1.55e-05	0.000228	CcSEcCtD
Ifosfamide—Chills—Epirubicin—ovarian cancer	1.55e-05	0.000227	CcSEcCtD
Ifosfamide—Arrhythmia—Epirubicin—ovarian cancer	1.54e-05	0.000226	CcSEcCtD
Ifosfamide—Visual impairment—Doxorubicin—ovarian cancer	1.54e-05	0.000226	CcSEcCtD
Ifosfamide—Asthenia—Paclitaxel—ovarian cancer	1.54e-05	0.000226	CcSEcCtD
Ifosfamide—Alopecia—Epirubicin—ovarian cancer	1.52e-05	0.000224	CcSEcCtD
Ifosfamide—Pruritus—Paclitaxel—ovarian cancer	1.51e-05	0.000223	CcSEcCtD
Ifosfamide—Mental disorder—Epirubicin—ovarian cancer	1.51e-05	0.000222	CcSEcCtD
Ifosfamide—Erythema multiforme—Doxorubicin—ovarian cancer	1.51e-05	0.000222	CcSEcCtD
Ifosfamide—Erythema—Epirubicin—ovarian cancer	1.5e-05	0.000221	CcSEcCtD
Ifosfamide—Malnutrition—Epirubicin—ovarian cancer	1.5e-05	0.000221	CcSEcCtD
Ifosfamide—Feeling abnormal—Docetaxel—ovarian cancer	1.49e-05	0.00022	CcSEcCtD
Ifosfamide—Eye disorder—Doxorubicin—ovarian cancer	1.49e-05	0.000219	CcSEcCtD
Ifosfamide—Tinnitus—Doxorubicin—ovarian cancer	1.49e-05	0.000219	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Docetaxel—ovarian cancer	1.48e-05	0.000218	CcSEcCtD
Ifosfamide—Cardiac disorder—Doxorubicin—ovarian cancer	1.48e-05	0.000218	CcSEcCtD
Ifosfamide—Flushing—Doxorubicin—ovarian cancer	1.48e-05	0.000218	CcSEcCtD
Ifosfamide—Diarrhoea—Paclitaxel—ovarian cancer	1.46e-05	0.000215	CcSEcCtD
Ifosfamide—Angiopathy—Doxorubicin—ovarian cancer	1.45e-05	0.000213	CcSEcCtD
Ifosfamide—Immune system disorder—Doxorubicin—ovarian cancer	1.44e-05	0.000212	CcSEcCtD
Ifosfamide—Mediastinal disorder—Doxorubicin—ovarian cancer	1.44e-05	0.000211	CcSEcCtD
Ifosfamide—Abdominal pain—Docetaxel—ovarian cancer	1.43e-05	0.000211	CcSEcCtD
Ifosfamide—Body temperature increased—Docetaxel—ovarian cancer	1.43e-05	0.000211	CcSEcCtD
Ifosfamide—Chills—Doxorubicin—ovarian cancer	1.43e-05	0.00021	CcSEcCtD
Ifosfamide—Arrhythmia—Doxorubicin—ovarian cancer	1.42e-05	0.000209	CcSEcCtD
Ifosfamide—Dizziness—Paclitaxel—ovarian cancer	1.42e-05	0.000208	CcSEcCtD
Ifosfamide—Vision blurred—Epirubicin—ovarian cancer	1.41e-05	0.000208	CcSEcCtD
Ifosfamide—Alopecia—Doxorubicin—ovarian cancer	1.41e-05	0.000207	CcSEcCtD
Ifosfamide—Mental disorder—Doxorubicin—ovarian cancer	1.4e-05	0.000205	CcSEcCtD
Ifosfamide—Ill-defined disorder—Epirubicin—ovarian cancer	1.39e-05	0.000205	CcSEcCtD
Ifosfamide—Erythema—Doxorubicin—ovarian cancer	1.39e-05	0.000204	CcSEcCtD
Ifosfamide—Malnutrition—Doxorubicin—ovarian cancer	1.39e-05	0.000204	CcSEcCtD
Ifosfamide—Anaemia—Epirubicin—ovarian cancer	1.39e-05	0.000204	CcSEcCtD
Ifosfamide—Agitation—Epirubicin—ovarian cancer	1.38e-05	0.000203	CcSEcCtD
Ifosfamide—Vomiting—Paclitaxel—ovarian cancer	1.36e-05	0.0002	CcSEcCtD
Ifosfamide—Malaise—Epirubicin—ovarian cancer	1.35e-05	0.000199	CcSEcCtD
Ifosfamide—Rash—Paclitaxel—ovarian cancer	1.35e-05	0.000198	CcSEcCtD
Ifosfamide—Dermatitis—Paclitaxel—ovarian cancer	1.35e-05	0.000198	CcSEcCtD
Ifosfamide—Vertigo—Epirubicin—ovarian cancer	1.35e-05	0.000198	CcSEcCtD
Ifosfamide—Leukopenia—Epirubicin—ovarian cancer	1.34e-05	0.000197	CcSEcCtD
Ifosfamide—Hypersensitivity—Docetaxel—ovarian cancer	1.34e-05	0.000197	CcSEcCtD
Ifosfamide—Palpitations—Epirubicin—ovarian cancer	1.32e-05	0.000195	CcSEcCtD
Ifosfamide—Cough—Epirubicin—ovarian cancer	1.31e-05	0.000192	CcSEcCtD
Ifosfamide—Vision blurred—Doxorubicin—ovarian cancer	1.31e-05	0.000192	CcSEcCtD
Ifosfamide—Asthenia—Docetaxel—ovarian cancer	1.3e-05	0.000191	CcSEcCtD
Ifosfamide—Convulsion—Epirubicin—ovarian cancer	1.3e-05	0.000191	CcSEcCtD
Ifosfamide—Hypertension—Epirubicin—ovarian cancer	1.29e-05	0.00019	CcSEcCtD
Ifosfamide—Ill-defined disorder—Doxorubicin—ovarian cancer	1.29e-05	0.000189	CcSEcCtD
Ifosfamide—Pruritus—Docetaxel—ovarian cancer	1.28e-05	0.000189	CcSEcCtD
Ifosfamide—Anaemia—Doxorubicin—ovarian cancer	1.28e-05	0.000189	CcSEcCtD
Ifosfamide—Myalgia—Epirubicin—ovarian cancer	1.28e-05	0.000188	CcSEcCtD
Ifosfamide—Arthralgia—Epirubicin—ovarian cancer	1.28e-05	0.000188	CcSEcCtD
Ifosfamide—Chest pain—Epirubicin—ovarian cancer	1.28e-05	0.000188	CcSEcCtD
Ifosfamide—Agitation—Doxorubicin—ovarian cancer	1.27e-05	0.000187	CcSEcCtD
Ifosfamide—Nausea—Paclitaxel—ovarian cancer	1.27e-05	0.000187	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	1.27e-05	0.000186	CcSEcCtD
Ifosfamide—Discomfort—Epirubicin—ovarian cancer	1.26e-05	0.000185	CcSEcCtD
Ifosfamide—Malaise—Doxorubicin—ovarian cancer	1.25e-05	0.000184	CcSEcCtD
Ifosfamide—Vertigo—Doxorubicin—ovarian cancer	1.25e-05	0.000183	CcSEcCtD
Ifosfamide—Leukopenia—Doxorubicin—ovarian cancer	1.24e-05	0.000183	CcSEcCtD
Ifosfamide—Diarrhoea—Docetaxel—ovarian cancer	1.24e-05	0.000183	CcSEcCtD
Ifosfamide—Confusional state—Epirubicin—ovarian cancer	1.23e-05	0.000181	CcSEcCtD
Ifosfamide—Palpitations—Doxorubicin—ovarian cancer	1.23e-05	0.00018	CcSEcCtD
Ifosfamide—Anaphylactic shock—Epirubicin—ovarian cancer	1.22e-05	0.00018	CcSEcCtD
Ifosfamide—Oedema—Epirubicin—ovarian cancer	1.22e-05	0.00018	CcSEcCtD
Ifosfamide—Infection—Epirubicin—ovarian cancer	1.22e-05	0.000179	CcSEcCtD
Ifosfamide—Cough—Doxorubicin—ovarian cancer	1.21e-05	0.000178	CcSEcCtD
Ifosfamide—Convulsion—Doxorubicin—ovarian cancer	1.2e-05	0.000177	CcSEcCtD
Ifosfamide—Nervous system disorder—Epirubicin—ovarian cancer	1.2e-05	0.000176	CcSEcCtD
Ifosfamide—Dizziness—Docetaxel—ovarian cancer	1.2e-05	0.000176	CcSEcCtD
Ifosfamide—Thrombocytopenia—Epirubicin—ovarian cancer	1.2e-05	0.000176	CcSEcCtD
Ifosfamide—Hypertension—Doxorubicin—ovarian cancer	1.2e-05	0.000176	CcSEcCtD
Ifosfamide—Skin disorder—Epirubicin—ovarian cancer	1.19e-05	0.000175	CcSEcCtD
Ifosfamide—Hyperhidrosis—Epirubicin—ovarian cancer	1.18e-05	0.000174	CcSEcCtD
Ifosfamide—Arthralgia—Doxorubicin—ovarian cancer	1.18e-05	0.000174	CcSEcCtD
Ifosfamide—Myalgia—Doxorubicin—ovarian cancer	1.18e-05	0.000174	CcSEcCtD
Ifosfamide—Chest pain—Doxorubicin—ovarian cancer	1.18e-05	0.000174	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	1.17e-05	0.000173	CcSEcCtD
Ifosfamide—Discomfort—Doxorubicin—ovarian cancer	1.17e-05	0.000172	CcSEcCtD
Ifosfamide—Anorexia—Epirubicin—ovarian cancer	1.17e-05	0.000172	CcSEcCtD
Ifosfamide—Vomiting—Docetaxel—ovarian cancer	1.15e-05	0.00017	CcSEcCtD
Ifosfamide—Rash—Docetaxel—ovarian cancer	1.14e-05	0.000168	CcSEcCtD
Ifosfamide—Hypotension—Epirubicin—ovarian cancer	1.14e-05	0.000168	CcSEcCtD
Ifosfamide—Dermatitis—Docetaxel—ovarian cancer	1.14e-05	0.000168	CcSEcCtD
Ifosfamide—Confusional state—Doxorubicin—ovarian cancer	1.14e-05	0.000168	CcSEcCtD
Ifosfamide—Anaphylactic shock—Doxorubicin—ovarian cancer	1.13e-05	0.000167	CcSEcCtD
Ifosfamide—Oedema—Doxorubicin—ovarian cancer	1.13e-05	0.000167	CcSEcCtD
Ifosfamide—Infection—Doxorubicin—ovarian cancer	1.12e-05	0.000165	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	1.11e-05	0.000164	CcSEcCtD
Ifosfamide—Nervous system disorder—Doxorubicin—ovarian cancer	1.11e-05	0.000163	CcSEcCtD
Ifosfamide—Thrombocytopenia—Doxorubicin—ovarian cancer	1.11e-05	0.000163	CcSEcCtD
Ifosfamide—Skin disorder—Doxorubicin—ovarian cancer	1.1e-05	0.000162	CcSEcCtD
Ifosfamide—Paraesthesia—Epirubicin—ovarian cancer	1.1e-05	0.000162	CcSEcCtD
Ifosfamide—Hyperhidrosis—Doxorubicin—ovarian cancer	1.09e-05	0.000161	CcSEcCtD
Ifosfamide—Dyspnoea—Epirubicin—ovarian cancer	1.09e-05	0.00016	CcSEcCtD
Ifosfamide—Somnolence—Epirubicin—ovarian cancer	1.09e-05	0.00016	CcSEcCtD
Ifosfamide—Anorexia—Doxorubicin—ovarian cancer	1.08e-05	0.000159	CcSEcCtD
Ifosfamide—Nausea—Docetaxel—ovarian cancer	1.08e-05	0.000158	CcSEcCtD
Ifosfamide—Decreased appetite—Epirubicin—ovarian cancer	1.06e-05	0.000156	CcSEcCtD
Ifosfamide—Hypotension—Doxorubicin—ovarian cancer	1.06e-05	0.000156	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Epirubicin—ovarian cancer	1.06e-05	0.000155	CcSEcCtD
Ifosfamide—Fatigue—Epirubicin—ovarian cancer	1.05e-05	0.000155	CcSEcCtD
Ifosfamide—Constipation—Epirubicin—ovarian cancer	1.05e-05	0.000154	CcSEcCtD
Ifosfamide—Pain—Epirubicin—ovarian cancer	1.05e-05	0.000154	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	1.03e-05	0.000152	CcSEcCtD
Ifosfamide—Paraesthesia—Doxorubicin—ovarian cancer	1.02e-05	0.00015	CcSEcCtD
Ifosfamide—Dyspnoea—Doxorubicin—ovarian cancer	1.01e-05	0.000148	CcSEcCtD
Ifosfamide—Feeling abnormal—Epirubicin—ovarian cancer	1.01e-05	0.000148	CcSEcCtD
Ifosfamide—Somnolence—Doxorubicin—ovarian cancer	1.01e-05	0.000148	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Epirubicin—ovarian cancer	1e-05	0.000147	CcSEcCtD
Ifosfamide—Decreased appetite—Doxorubicin—ovarian cancer	9.84e-06	0.000145	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	9.77e-06	0.000144	CcSEcCtD
Ifosfamide—Fatigue—Doxorubicin—ovarian cancer	9.76e-06	0.000144	CcSEcCtD
Ifosfamide—Urticaria—Epirubicin—ovarian cancer	9.72e-06	0.000143	CcSEcCtD
Ifosfamide—Pain—Doxorubicin—ovarian cancer	9.68e-06	0.000142	CcSEcCtD
Ifosfamide—Constipation—Doxorubicin—ovarian cancer	9.68e-06	0.000142	CcSEcCtD
Ifosfamide—Body temperature increased—Epirubicin—ovarian cancer	9.67e-06	0.000142	CcSEcCtD
Ifosfamide—Abdominal pain—Epirubicin—ovarian cancer	9.67e-06	0.000142	CcSEcCtD
Ifosfamide—Feeling abnormal—Doxorubicin—ovarian cancer	9.33e-06	0.000137	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Doxorubicin—ovarian cancer	9.26e-06	0.000136	CcSEcCtD
Ifosfamide—Hypersensitivity—Epirubicin—ovarian cancer	9.01e-06	0.000133	CcSEcCtD
Ifosfamide—Urticaria—Doxorubicin—ovarian cancer	8.99e-06	0.000132	CcSEcCtD
Ifosfamide—Abdominal pain—Doxorubicin—ovarian cancer	8.95e-06	0.000132	CcSEcCtD
Ifosfamide—Body temperature increased—Doxorubicin—ovarian cancer	8.95e-06	0.000132	CcSEcCtD
Ifosfamide—Asthenia—Epirubicin—ovarian cancer	8.78e-06	0.000129	CcSEcCtD
Ifosfamide—Pruritus—Epirubicin—ovarian cancer	8.66e-06	0.000127	CcSEcCtD
Ifosfamide—Diarrhoea—Epirubicin—ovarian cancer	8.37e-06	0.000123	CcSEcCtD
Ifosfamide—Hypersensitivity—Doxorubicin—ovarian cancer	8.34e-06	0.000123	CcSEcCtD
Ifosfamide—Asthenia—Doxorubicin—ovarian cancer	8.12e-06	0.000119	CcSEcCtD
Ifosfamide—Dizziness—Epirubicin—ovarian cancer	8.09e-06	0.000119	CcSEcCtD
Ifosfamide—Pruritus—Doxorubicin—ovarian cancer	8.01e-06	0.000118	CcSEcCtD
Ifosfamide—Vomiting—Epirubicin—ovarian cancer	7.78e-06	0.000114	CcSEcCtD
Ifosfamide—Diarrhoea—Doxorubicin—ovarian cancer	7.75e-06	0.000114	CcSEcCtD
Ifosfamide—Rash—Epirubicin—ovarian cancer	7.71e-06	0.000113	CcSEcCtD
Ifosfamide—Dermatitis—Epirubicin—ovarian cancer	7.71e-06	0.000113	CcSEcCtD
Ifosfamide—Dizziness—Doxorubicin—ovarian cancer	7.49e-06	0.00011	CcSEcCtD
Ifosfamide—Nausea—Epirubicin—ovarian cancer	7.27e-06	0.000107	CcSEcCtD
Ifosfamide—Vomiting—Doxorubicin—ovarian cancer	7.2e-06	0.000106	CcSEcCtD
Ifosfamide—Rash—Doxorubicin—ovarian cancer	7.14e-06	0.000105	CcSEcCtD
Ifosfamide—Dermatitis—Doxorubicin—ovarian cancer	7.13e-06	0.000105	CcSEcCtD
Ifosfamide—Nausea—Doxorubicin—ovarian cancer	6.72e-06	9.89e-05	CcSEcCtD
